Corbenic Partners’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-33
| Closed | – | – | 276 |
|
|
2017
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 211 |
|
|
2017
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 228 |
|
|
2016
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 223 |
|
|
2016
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 233 |
|
|
2016
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 197 |
|
|
2016
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 201 |
|
|
2015
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 212 |
|
|
2015
Q3 | $1K | Hold |
33
| – | – | ﹤0.01% | 162 |
|
|
2015
Q2 | $1K | Hold |
33
| – | – | ﹤0.01% | 143 |
|
|
2015
Q1 | $0 | Sell |
33
-14
| -30% | – | ﹤0.01% | 231 |
|
|
2014
Q4 | $1K | Buy |
47
+14
| +42% | +$298 | ﹤0.01% | 221 |
|
|
2014
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 142 |
|
|
2014
Q2 | $1K | Hold |
33
| – | – | ﹤0.01% | 107 |
|
|
2014
Q1 | $1K | Hold |
33
| – | – | ﹤0.01% | 107 |
|
|
2013
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 122 |
|
|
2013
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 129 |
|
|
2013
Q2 | $0 | Buy |
+33
| New | – | ﹤0.01% | 114 |
|